XML 29 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Changes in Stockholders’ Deficit (Unaudited) - USD ($)
Common Stock
Previously Reported
Class A
Common Stock
Previously Reported
Class B
Common Stock
Class A
Common Stock
Class B
Common Stock
Additional Paid-In Capital
Previously Reported
Additional Paid-In Capital
Accumulated Deficit
Previously Reported
Accumulated Deficit
Preferred Stock
Convertible Preferred Stock
Previously Reported
Total
Balance at Dec. 31, 2022     $ 98 $ 861       $ (8,501,776)     $ (8,500,817)
Balance (in Shares) at Dec. 31, 2022     976,081 8,615,141                
Excise taxes on stock redemption           (967,916)     (967,916)
Conversion of Class B common stock to Class A common stock     $ 861 $ (861)          
Conversion of Class B common stock to Class A common stock (in Shares)     8,615,141 (8,615,141)                
Contribution for non-redemption agreements           708,400     708,400
Accretion of Class A common stock subject to possible redemption         (1,720,054)   (6,979,217)     (8,699,271)
Waiver of Deferred Underwriter’s Fee         8,704,270       8,704,270
Net income (loss)           4,443,634     4,443,634
Balance at Dec. 31, 2023 $ 959     $ 707 $ 6,984,216 27,825,061 $ (11,296,875) (36,259,736) $ 1,237 $ (4,311,700) (8,432,731)
Balance (in Shares) at Dec. 31, 2023 9,591,222     7,072,300         12,364,815    
Retroactive application of recapitalization         $ (123)   340   $ (217)  
Retroactive application of recapitalization (in Shares)         (1,235,418)         (2,159,935)    
Net income (loss)             (945,046)   (945,046)
Balance at Mar. 31, 2024         $ 584   27,825,401   (37,204,782) $ 1,020   (9,377,777)
Balance (in Shares) at Mar. 31, 2024         5,836,882         10,204,880    
Balance at Dec. 31, 2023 $ 959     $ 707 6,984,216 27,825,061 (11,296,875) (36,259,736) $ 1,237 (4,311,700) (8,432,731)
Balance (in Shares) at Dec. 31, 2023 9,591,222     7,072,300         12,364,815    
Fair value of shares transferred to non-redeeming stockholders       838,825       838,825  
Discount on note payable for subscription shares       434,696       434,696  
Excise taxes on stock redemption         (1,167,245)     (1,167,245)  
Accretion of Class A common stock subject to possible redemption       (2,248,962)       (2,248,962)  
Net income (loss)         (1,868,532)     (1,868,532) (1,868,532)
Balance at Dec. 31, 2024 $ 959     $ 584 $ 6,008,775 33,537,989 $ (14,332,652) (101,348,522) $ 1,020 $ (8,322,918) (67,808,929)
Balance (in Shares) at Dec. 31, 2024 9,591,222     5,836,882         10,204,880    
Net income (loss)             (48,879,200)   (48,879,200)
Reverse recapitalization, net of expenses         $ 3,916   173,821,544   $ (1,020)   173,824,440
Reverse recapitalization, net of expenses (in Shares)         39,163,783         (10,204,880)    
Share based compensation expense           5,170,275     5,170,275
Exercise of Series B warrants         $ 50   (50)    
Exercise of Series B warrants (in Shares)         500,000             500,000
Issuance of March 2025 Closing Shares and Warrants         $ 75   9,569,109     $ 9,569,184
Issuance of March 2025 Closing Shares and Warrants (in Shares)         750,000              
Balance at Mar. 31, 2025         $ 4,625   $ 222,098,867   $ (150,227,722)   $ 71,875,770
Balance (in Shares) at Mar. 31, 2025         46,250,665